Skip to main content
Barbara Weckler

Barbara Weckler

Dr. med. Barbara Weckler is a pulmonologist and clinician-scientist at University Hospital Marburg (UKGM), where she serves as Chief Physician (Oberärztin) and Head of the Outpatient Clinic for Respiratory Infections, including Long COVID, at Philipps-Universität Marburg.

Aug 5, 2026

10:34
So what did anything change in your practice now that that you were able to show this and show this prospectively that indeed, if someone comes with community acquired pneumonia and they have low eosinophil counts, do you have like a lower threshold to send them to the ICU? Like, has it has anything in your practice changed?
10:58
So I think now we actually know that eosinopenia can kind of flag high-risk patients.
11:05
So if I have two patients with the same number of comorbidities and one of them is eosinopenic, I would make that a high-risk patient and simply favor that patient to be put on a monitor, for example, or also to be sent to an intensive care unit over a patient who doesn't have eosinopenia but i have to say and we also divided patients in based on a threshold that we defined and we defined a threshold of 10 per 10 cells per microliter to separate patients into a high risk group and a low risk group so we found that 14.2 percent of patients um were sent to um required intensive care unit admission as opposed to 8.5% in non-eosinopenic patients.
12:02
And because you can see that patients have a higher rate of intensive care unit admission, we actually see those patients as high-risk patients.
12:14
But you also see that patients who are not eosinopenic also have a administer an intensive care rate of 8.5 so that's not zero so I wouldn't consider them stable patients you know there are more factors that we have to to consider than eosinopenia in those patients to make the decision on whether to send them to intensive care unit
14:47
What is next for your team?
14:51
So at the end of the day, I think we should answer the question why eosinopenia is associated with tuberculosis.
15:00
more hospital resources and also adverse outcomes in community acquired pneumonia.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.